Monday, May 23, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Cuba to submit dossier for Covid-19 Abdala vaccine


Cuba to submit dossier for Covid-19 Abdala vaccine

Havana, Mar 2 (Prensa Latina) The Center for Genetic Engineering and Biotechnology of Cuba (CIGB) on Wednesday reiterated its interest in initiating the process to submit the dossier of the Abdala vaccine against Covid-19 to the World Health Organization (WHO).
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

“CIGBCuba expressed its interest in initiating the process of submitting the Abdala vaccine’s dossier to the WHO and the Pan-American Health Organization (PAHO) for evaluation,” according to a message from the institution on Twitter.

Recently, the scientific institution explained that the BioCubaFarma Business Group and the Center for State Control of Medicines, Equipment and Medical Devices maintain exchanges with experts from these international organizations.

Gerardo Guillen, director of Biomedical Research at the CIGB, acknowledged that the results of science in the field of vaccines were possible thanks to Cuba’s socialist system, the integration of institutions and the accumulated scientific experience.

Likewise, Cuba has the necessary equipment and reserves of supplies that made it possible to focus on these projects, to which was added the support of the Government to integrate and coordinate actions, Guillen commented.

Abdala, with 92.28-percent efficacy, is the first vaccine in Latin America against Covid-19.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.